Yüklüyor......
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
BACKGROUND: Vadadustat, an inhibitor of hypoxia-inducible factor prolyl-4-hydroxylase domain dioxygenases, is an oral investigational agent in development for the treatment of anemia secondary to chronic kidney disease. METHODS: In this open-label Phase 2 trial, vadadustat was evaluated in 94 subjec...
Kaydedildi:
| Yayımlandı: | Nephrol Dial Transplant |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6322440/ https://ncbi.nlm.nih.gov/pubmed/29672740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy055 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|